Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.56 (
insulin-degrading enzyme
)
737
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have investigated the biosynthesis, subcellular location and expression of
insulin-degrading enzyme
(
IDE
). a type-I peroxisomal protease, in semi-permeabilized hepatoma cells using pulse-chase experiments, non-denaturing immunoprecipitation protocols and Northern-blot analyses. In HcpG2 cell lysates prepared from cells radiolabelled with Tran[35S]-label, immunoprecipitated
IDE
was observed immediately after a 5 min pulse and subsequently declined during chase with t1/2 of approx. 33 h. In addition to the 110 kDa
IDE
protein, a protein of 70 kDa (p70) was identified in radiolabelled immunoprecipitates when using a monoclonal anti-
IDE
antibody 9B12 under non-denaturing conditions. This same antibody did not recognize p70 on Western blots of whole-cell lysates nor in sequential immunoprecipitates of immunocomplex-bead eluates from anti-
IDE
immunoprecipitations. Likewise, cross-linking studies performed on intact HepG2 and H35 hepatoma cells in vivo revealed the existence of a hetero-oligomeric complex of 180 kDa in which
IDE
and p70 were physically associated.
Digitonin
-permeabilization studies in normal and 35S-labelled HepG2 cells have defined a predominant association of
IDE
and its associated protein p70 with cytosol (supernatant); only a minor amount of the protein
IDE
was detected in peroxisomes (cellular pellet). Immunoprecipitation of
IDE
from 35S-labelled cell lysates of normal and stably transfected Chinese hamster ovary cells overexpressing
IDE
failed to detect p70. Treatment of HepG2 cells with clofibrate, a peroxisome proliferator, resulted in a dose-dependent increase of the two human
IDE
transcripts of 3.6 and 3.2 kb. This effect was not accompanied by a similar change at the protein level, nor by a change in the subcellular location of the proteins
IDE
and p70. Based on these findings we propose that in hepatoma cells: (1)
IDE
mainly exists in a stable cytoplasmic pool that is unchanged in cells undergoing peroxisomal proliferation; and (2) p70 binding to
IDE
may serve to maintain the dual cytosolic and peroxisomal pools of
IDE
in a stable equilibrium.
...
PMID:Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells. 887 Jun 62